Related Experiment Videos
How much longer will tumour cells fool the immune system?
S Ferrone1, J F Finerty, E M Jaffee
1Roswell Park Cancer Institute, Department of Immunology, Buffalo, NY 14263, USA. soldano.ferrone@roswellpark.org
Immunology Today
|March 11, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Methods for retrovirus-mediated gene transfer to tumor cells.
Methods in molecular medicine·2014
Methods for liposome-mediated gene transfer to the arterial wall.
Methods in molecular medicine·2014
Methods for liposome-mediated gene transfer to tumor cells in vivo.
Methods in molecular medicine·2014
Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans.
Clinical and vaccine immunology : CVI·2012
Gene transfer and cardiovascular disease.
Trends in cardiovascular medicine·2011
The origin and significance of anti-DNA antibodies.
Immunology today·2014
Mutations of class II MHC molecules.
Immunology today·2014
Antigen processing at the molecular level.
Immunology today·2014
Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.
Immunology today·2014
Are MHC class II-restricted cytotoxic T lymphocytes important?
Immunology today·2014
Complement and the regulation of humoral immune responses.
Immunology today·2014
Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms.
Current hematologic malignancy reports·2026
Assessment of bone involvement by DXA and HR-pQCT in patients with X-linked hypophosphatemia.
Journal of bone and mineral metabolism·2026
Cancer-associated pruritus: Insights into its pathogenesis and management.
The Journal of investigative dermatology·2026
Malignant esophageal perforation with pleural empyema: a successful robotic esophagectomy with primary reconstruction - a case report.
International journal of surgery case reports·2026